Structure (2c72dbc3 5385 4706 B5fd 841d4b70a26f 01)
Ranolazine Tablet, Extended Release
Product Images NDC 63629-4874
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 63629-4874). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lbl636294874)
This description provides important information about Ranolazine Extended-Release Tablets containing 500 mg of the active ingredient. It includes guidance on the usual dosage, storage conditions, and administration. The packaging is child-resistant, and it is advised to keep the tablets out of reach of children. The information also mentions a QR code for complete prescribing information and includes details such as the NDC number, manufacturer, and repackaging details. Overall, this text provides essential information about the tablet for users.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
